Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a USD125 million senior credit facility to support the recapitalisation of a healthcare services company.
The Riverside Company made a simultaneous minority investment as part of the transaction.
The unnamed company is a provider of information that helps doctors improve patients’ lives, with scientific capabilities that can identify potential chronic diseases at stages early enough to make patient lifestyle and wellness improvements successful.
